PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Cy3 Donkey anti-rabbit IgG (minimal x-reactivity), 100 μg
Cy3 Goat anti-mouse IgG (minimal x-reactivity), 100 μg
Cy3 Goat anti-rat IgG (minimal x-reactivity), 100 μg
Cy3 Streptavidin, 100 μg
Cy5 Streptavidin, 100 μg
DyLight™ 405 Goat anti-mouse IgG1, 100 μg
DyLight™ 488 Donkey anti-rabbit IgG (minimal x-reactivity), 100 μg
DyLight™ 488 Goat anti-hamster (Armenian) IgG, 100 μg
DyLight™ 488 Goat anti-mouse IgG (minimal x-reactivity), 100 μg
DyLight™ 488 Streptavidin, 100 μg
DyLight™ 594 Goat anti-hamster (Armenian) IgG, 100 μg
DyLight™ 649 Donkey anti-rabbit IgG (minimal x-reactivity), 100 μg
DyLight™ 649 Goat anti-hamster (Armenian) IgG, 100 μg
DyLight™ 649 Goat anti-mouse IgG (minimal x-reactivity), 100 μg
DyLight™ 649 Streptavidin, 100 μg
FITC anti-mouse Ig light chain κ, 50 μg